TNNT2

There are 50 papers on TNNT2 in aging research: 2 trials and 25 observational studies in people, 12 in animals, 9 in cells, 1 review. The newest story, Oct 28, 2026: “Model predicted cardiovascular risk in peritoneal dialysis patients”.

Gene

50 papers study it5 findings

HGNCNCBI GeneTaxon

7 new papers in 30 daysSee all 50 papers on TNNT2

At a glance

The findings reach mice, none yet in people. 3 independent labs in 3 countries; 3 trials.

None of its findings points the other way.

Cells and mice: a single group. Worms or flies and humans: nothing yet.
  • 3 independent labs in 3 countries
  • 3 trials
  • Funders: National Center for Advancing Translational Sciences and 8 more
  • 1 of 5 findings with company ties
  • 3 of 3 trials sponsored by developers of drugs aimed at it
  • Human trial2
  • Humans25
  • Animals12
  • Cells9

Interventions

2

Pracinostat

upin mouse cells1

1 study
  1. Pracinostat increases TNNT2 in mouse cells (5-fold).

    Cellssubcutaneous adipose tissue-derived stromal vascular fraction cells150 nM

More on Pracinostat

Biomatrix

upin human cells1

1 study
  1. Biomatrix increases TNNT2 in human cells (cultured on biomatrix).

    Cellscultured on biomatrixadult human cardiac fibroblasts

More on Biomatrix

Effects

3

Motor activity

downin mice1

1 study
  1. TNNT2 impairs motor activity in mice with age.

    Animalswith ageskeletal muscle

Neurotransmission efficiency

downin mice1

1 study
  1. TNNT2 impairs neurotransmission efficiency in mice.

    Animalsfast skeletal muscle

Muscle denervation markers

downin mice1

1 study
  1. TNNT2 decreases muscle denervation markers in mice.

    Animalsfast skeletal muscle

More on Muscle denervation markers

Latest

Dec 2025: 1Jan 2026: 5Feb 2026: 2Mar 2026: 3Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 1Aug 2026: 0Sep 2026: 3Oct 2026: 3Nov 2026: 422 papers in 12 months
Clinical and Translational Medicine

Model predicted cardiovascular risk in peritoneal dialysis patients

The model scored 0.822 in external validation, compared with 0.784 in training and 0.781 in internal testing, on a measure of its ability to distinguish disease.The model scored 0.822 in external validation, compared with 0.784 in training and 0.781 in internal testing, on a measure of its ability to distinguish disease.

Cohort · 102 peopleCardiovascular disease

See all 50 papers on TNNT2